Polymer-supported CuPd nanoalloy as a synergistic catalyst for electrocatalytic reduction of carbon dioxide to methane

Photo- and electrochemical CO2 reduction to carbon fuels is not only an attractive solution to the greenhouse effect, but could also become an integral part of a global energy storage strategy with renewable electrical energy sources used to store energy in the chemical bonds of carbon fuels. A novel electrodeposition strategy is reported here for the preparation of highly dispersed, ultrafine metal nanoparticles and nanoalloys on an electroactive polymeric film. It is shown that a bimetallic Cu–Pd nanoalloy exhibits a greater than twofold enhancement in Faradaic efficiency for CO2 reduction to methane compared with a state-of-the-art nanoCu catalyst. The fabrication procedure for the alloy nanoparticles is straightforward and applicable as a general procedure for catalytic electrodes for integrated electrolysis devices

Synthesis, characterization, and water oxidation by a molecular chromophore-catalyst assembly prepared by atomic layer deposition. The “mummy” strategy

A Ru( ii )-polypyridyl chromophore-catalyst assembly for light-assisted water oxidation is constructed using atomic layer deposition with no covalent bonds between molecules required for bilayer formation

Cystourethrography: The effect of reservoir height upon intravesical pressure

The effect of infusion height upon intravesical pressure during cystography was studied in three dogs and three patients. Results indicate that during bladder filling the intravesical pressure is independent of the reservoir height.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/46721/1/247_2004_Article_BF00973671.pd

Use of intermittent self-catheterisation for voiding dysfunction

An article detailing the use of intermittent self-catheterisation for voiding dysfunction

Water-loss (intracellular) dehydration assessed using urinary tests, how well do they work? Diagnostic accuracy in older people

Background: Water-loss dehydration (hypertonic, hyperosmotic or intra-cellular dehydration) is due to insufficient fluid intake and distinct from hypovolemia due to excess fluid losses. It is associated with poor health outcomes such as disability and mortality in older people. Urine specific gravity (USG), color and urine osmolality have been widely advocated for screening for dehydration in older adults. Objective: To assess the diagnostic accuracy of urinary measures to screen for water-loss dehydration in older people.Design: This was a diagnostic accuracy study of people aged ≥65years taking part in the Dehydration Recognition In our Elders (DRIE, living in long-term care) or Dietary Strategies for Healthy Ageing in Europe (NU-AGE, living in the community) studies. The reference standard was serum osmolality, index tests included USG, urine color, osmolality, cloudiness, additional dipstick measures, ability to provide a urine sample, and volume of a random urine sample. Minimum useful diagnostic accuracy was set at sensitivity and specificity ≥70% or receiver operating characteristics plot area under the curve ≥0.70. Results: DRIE participants (67% women, mean age 86 years, n=162) had more limited cognitive and functional abilities than NU-AGE participants (64% women, mean age 70 years, n=151). 19% of DRIE and 22% of NU-AGE participants were dehydrated (serum osmolality >300mOsm/kg). Neither USG nor any other potential urinary tests were usefully diagnostic for water-loss dehydration. Conclusions: Although USG, urine color and urinary osmolality have been widely advocated for screening for dehydration in older adults, we show in the largest study to date that their diagnostic accuracy is too low to be useful and these measures should not be used to indicate hydration status in older people (either alone or as part of a wider tranche of tests). There is a need to develop simple, inexpensive and non-invasive tools for the assessment of dehydration in older people

The neurogenic bladder: medical treatment

Neurogenic bladder sphincter dysfunction (NBSD) can cause severe and irreversible renal damage and bladder-wall destruction years before incontinence becomes an issue. Therefore, the first step in adequate management is to recognize early the bladder at risk for upper- and lower-tract deterioration and to start adequate medical treatment proactively. Clean intermittent catheterization combined with anticholinergics (oral or intravesical) is the standard therapy for NBSD. Early institution of such treatment can prevent both renal damage and secondary bladder-wall changes, thereby potentially improving long-term outcomes. In children with severe side effects or with insufficient suppression of detrusor overactivity despite maximal dosage of oral oxybutynin, intravesical instillation is an effective alternative. Intravesical instillation eliminates systemic side effects by reducing the first-pass metabolism and, compared with oral oxybutynin, intravesical oxybutynin is a more potent and long-acting detrusor suppressor. There is growing evidence that with early adequate treatment, kidneys are saved and normal bladder growth can be achieved in children so they will no longer need surgical bladder augmentation to achieve safe urinary continence in adolescence and adulthood